Key facts
- Maven Health’s last known valuation is $5.8M (Apr 2025).
- It has raised $570K; the latest was Seed Round ($410K) in Apr 2025.
- Notable investors include Venture Kick, Ecole Polytechnique Federale de Lausanne, S2S Ventures, DayOne Accelerator, Founderful Campus — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Maven Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Maven Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Maven Health
Developer of a metabolic health assessment platform designed to support healthcare professionals in identifying at-risk individuals before traditional diagnostics. The company uses saliva-based metabolite measurements analyzed through customized Nuclear Magnetic Resonance (NMR) spectrometry, enabling registered nutritionists and healthcare providers to assess metabolic health with minimal invasiveness, competitive cost, and early detection capabilities.
- Sector
- Healthcare
- HQ
- Zurich, Switzerland
- Founded
- 2022
- Employees
- 3
- Website
- mavenhealth.ch/en
- Ownership
- Privately Held (backing)
Maven Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Maven Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Maven Health in its N-PORT filings yet. We sweep new filings monthly.